Skip to main content
. 2012 Jul 25;7(7):e41746. doi: 10.1371/journal.pone.0041746

Figure 5. CCL18 serum level and survival time of patients with adenocarcinoma of the lung in days from time point of diagnosis.

Figure 5

Survival time of patients with different serum CCL18 levels varies significantly in adenocarcinoma patients (p<0.002; A) but not in patients with squamous carcinoma (B, left panel) and mixed NSCLC (B, right panel).